Loading viewer...
investor_presentation
Format: PDF investor_presentation
Earnings Release Q1 FY 2022 Results October 19, 2021
October 19, 2021Strategic
PrioritiesIMMEDIATE PRIORITIES
1.Ensuring the health and safety of our P&G
colleagues around the world.
2.Maximizing the availability of products we produce
to help people and their families with their cleaning,
health and hygiene needs.
3.Supporting communities, relief agencies and people
who are on the front lines of this global pandemic.
LEADING CONSTRUCTIVE DISRUPTION
FOCUSED & AGILE ORGANIZATIONSTRATEGIC FOCUS AREAS
PORTFOLIO : DAILY USE, PERFORMANCE DRIVES BRAND CHOICE
PRODUCTIVITY TO FUEL INVESTMENTS
Products Packaging ValueNew Standard
Communication Retail ExecutionBusiness Results
Q1 FY 2022Organic sales grew +4% driven by volume, pricing and mix.
9 of our 10 product categories grew organic sales versus year ago.
Aggregate market share growth of 50 basis points.
On track to deliver guidance on organic sales growth, core EPS growth,
adjusted free cash flow productivity and cash return to shareowners.
Focus remains on executing our strategies to deliver balanced top -line and
bottom -line growth along with strong cash generation.Q1 FY 2022
Organic Sales Growth
Organic Volume Growth
Flow ProductivityQ1 FY ‘22
Core EPS Growth -3%Q1 FY 2022 RESULTS
Q1 FY '21 Q2 FY '21 Q3 FY '21 Q4 FY '21 Q1 FY '22Volume contributed 2 points of organic sales
growth. Pricing and mix each added a point.ORGANIC SALES GROWTH
Q1 FY 2022 RESULTS19%
Q1 FY '21 Q2 FY '21 Q3 FY '21 Q4 FY '21 Q1 FY '22•Core gross margin -370basis points
Preview truncated — download the full document for the complete content.
conference
27 Pages
investor_presentation
34 Pages
Morgan Stanley
Omega Healthcare Investors 2021 Investor Presentation
investor_presentationinvestor_presentation
65 Pages
Omega Healthcare Investors
investor_presentation
DKSH Holding Limited